These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 16034144)

  • 21. 1alpha,25-dihydroxyvitamin D3 induces an autoantigen-specific T-helper 1/T-helper 2 immune shift in NOD mice immunized with GAD65 (p524-543).
    Overbergh L; Decallonne B; Waer M; Rutgeerts O; Valckx D; Casteels KM; Laureys J; Bouillon R; Mathieu C
    Diabetes; 2000 Aug; 49(8):1301-7. PubMed ID: 10923629
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Active tolerance induction and prevention of autoimmune diabetes by immunogene therapy using recombinant adenoassociated virus expressing glutamic acid decarboxylase 65 peptide GAD(500-585).
    Han G; Li Y; Wang J; Wang R; Chen G; Song L; Xu R; Yu M; Wu X; Qian J; Shen B
    J Immunol; 2005 Apr; 174(8):4516-24. PubMed ID: 15814672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Type 1 diabetes-predisposing MHC alleles influence the selection of glutamic acid decarboxylase (GAD) 65-specific T cells in a transgenic model.
    Abraham RS; Wen L; Marietta EV; David CS
    J Immunol; 2001 Jan; 166(2):1370-9. PubMed ID: 11145722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The class II MHC I-Ag7 molecules from non-obese diabetic mice are poor peptide binders.
    Carrasco-Marin E; Shimizu J; Kanagawa O; Unanue ER
    J Immunol; 1996 Jan; 156(2):450-8. PubMed ID: 8543793
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epitope dominance: evidence for reciprocal determinant spreading to glutamic acid decarboxylase in non-obese diabetic mice.
    Zechel MA; Krawetz MD; Singh B
    Immunol Rev; 1998 Aug; 164():111-8. PubMed ID: 9795769
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endogenous expression levels of autoantigens influence success or failure of DNA immunizations to prevent type 1 diabetes: addition of IL-4 increases safety.
    Wolfe T; Bot A; Hughes A; Möhrle U; Rodrigo E; Jaume JC; Baekkeskov S; von Herrath M
    Eur J Immunol; 2002 Jan; 32(1):113-21. PubMed ID: 11754351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic alteration of insulin-dependent diabetes mellitus progression by T cell tolerance to glutamic acid decarboxylase 65 peptides in vitro and in vivo.
    Wilson SS; White TC; DeLuca D
    J Immunol; 2001 Jul; 167(1):569-77. PubMed ID: 11418696
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disease prevention with islet autoantigens.
    Eisenbarth GS; Jasinski JM
    Endocrinol Metab Clin North Am; 2004 Mar; 33(1):59-73, viii. PubMed ID: 15053895
    [No Abstract]   [Full Text] [Related]  

  • 29. Th1 to Th2 cytokine shifts in nonobese diabetic mice: sometimes an outcome, rather than the cause, of diabetes resistance elicited by immunostimulation.
    Serreze DV; Chapman HD; Post CM; Johnson EA; Suarez-Pinzon WL; Rabinovitch A
    J Immunol; 2001 Jan; 166(2):1352-9. PubMed ID: 11145720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence for molecular mimicry between human T cell epitopes in rotavirus and pancreatic islet autoantigens.
    Honeyman MC; Stone NL; Falk BA; Nepom G; Harrison LC
    J Immunol; 2010 Feb; 184(4):2204-10. PubMed ID: 20083660
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determinant spreading of T helper cell 2 (Th2) responses to pancreatic islet autoantigens.
    Tian J; Lehmann PV; Kaufman DL
    J Exp Med; 1997 Dec; 186(12):2039-43. PubMed ID: 9396773
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pancreas-infiltrating Th1 cells and diabetes develop in IL-12-deficient nonobese diabetic mice.
    Trembleau S; Penna G; Gregori S; Chapman HD; Serreze DV; Magram J; Adorini L
    J Immunol; 1999 Sep; 163(5):2960-8. PubMed ID: 10453045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. B lymphocytes are crucial antigen-presenting cells in the pathogenic autoimmune response to GAD65 antigen in nonobese diabetic mice.
    Falcone M; Lee J; Patstone G; Yeung B; Sarvetnick N
    J Immunol; 1998 Aug; 161(3):1163-8. PubMed ID: 9686575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. B cells are crucial for determinant spreading of T cell autoimmunity among beta cell antigens in diabetes-prone nonobese diabetic mice.
    Tian J; Zekzer D; Lu Y; Dang H; Kaufman DL
    J Immunol; 2006 Feb; 176(4):2654-61. PubMed ID: 16456028
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes.
    Kaufman DL; Clare-Salzler M; Tian J; Forsthuber T; Ting GS; Robinson P; Atkinson MA; Sercarz EE; Tobin AJ; Lehmann PV
    Nature; 1993 Nov; 366(6450):69-72. PubMed ID: 7694152
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isolation of self antigen-reactive cells from inflamed islets of nonobese diabetic mice using CD4high expression as a marker.
    Lejon K; Fathman CG
    J Immunol; 1999 Nov; 163(10):5708-14. PubMed ID: 10553102
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protection of NOD mice from type 1 diabetes after oral inoculation with vaccinia viruses expressing adjuvanted islet autoantigens.
    Denes B; Krausova V; Fodor N; Timiryasova T; Henderson D; Hough J; Yu J; Fodor I; Langridge WH
    J Immunother; 2005; 28(5):438-48. PubMed ID: 16113600
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice.
    Tian J; Zekzer D; Hanssen L; Lu Y; Olcott A; Kaufman DL
    J Immunol; 2001 Jul; 167(2):1081-9. PubMed ID: 11441119
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isolation of nonobese diabetic mouse T-cells that recognize novel autoantigens involved in the early events of diabetes.
    Gelber C; Paborsky L; Singer S; McAteer D; Tisch R; Jolicoeur C; Buelow R; McDevitt H; Fathman CG
    Diabetes; 1994 Jan; 43(1):33-9. PubMed ID: 8262314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retardation or acceleration of diabetes in NOD/Lt mice mediated by intrathymic administration of candidate beta-cell antigens.
    Cetkovic-Cvrlje M; Gerling IC; Muir A; Atkinson MA; Elliott JF; Leiter EH
    Diabetes; 1997 Dec; 46(12):1975-82. PubMed ID: 9392483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.